SCHEMBL6902160

SCHEMBL6902160

CCc1cc(Nc2cc(=O)n(CCCCCN3CCN(c4c(F)cc5c(=O)c(C(=O)O)c(CC)[nH]c5c4OC)CC3)c(=O)[nH]2)ccc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899561 0.92 — —
SCHEMBL6901659 0.92 — —
SCHEMBL6904722 0.91 — —
SCHEMBL6902995 0.91 — —
SCHEMBL6780000 0.84 — —
SCHEMBL6895954 0.84 — —
SCHEMBL6902087 0.84 — —
SCHEMBL6777662 0.84 — —
Hydrochloric Acid SCHEMBL6903799 0.84 — —
SCHEMBL6904998 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401829-A4 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX INC (US) 2004-10-27 — — EP disclosed
EP-1401829-A1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS Microbiotix, Inc. (US) 2004-03-31 — — EP disclosed
WO-2002102792-A1 NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS MICROBIOTIX, INC. (US) 2002-12-27 — — WO disclosed
Send feedback